[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "The Pfizer documents", "description": "Public Health and Medical Professionals for Transparency, Pfizer / FDA FOI\n\nhttps://phmpt.org\n\nRequest, Freedom of Information Act (FOIA) \n\nhttps://phmpt.org/wp-content/uploads/2021/10/IR0546-FDA-Pfizer-Approval-FINAL.pdf\n\nAgainst FDA\n\nhttps://phmpt.org/wp-content/uploads/2021/10/001-Complaint-101021.pdf\n\nThe court order\n\nhttps://phmpt.org/wp-content/uploads/2022/02/056-ORDER-GRANTING-IN-PART-THE-MOTION-TO-MODIFY-THE-PRODUCTION-SCHEDULE-AND-ADDOPTS-THE-JOINT-STATUS-REPORT-MODIFIED-AGREED-PRODUCTION-SCHEDULE.pdf\n\nList of downloadable documents\n\nhttps://phmpt.org/pfizers-documents/\n\n5.3.6 CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021 \n\nhttps://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf\n\nAdverse event reports \n\n01 December 2020 through 28 February 2021\n \nCumulatively, through 28 February 2021, \n\na total of 42,086 case reports (25,379 medically confirmed and 16,707 non-medically confirmed) \n\ncontaining 158,893 events. \n\nMost cases (34,762) were received from United States (13,739), \n\nUnited Kingdom (13,404) \n\nItaly (2,578), \n\nGermany (1,913), \n\nFrance (1,506), \n\nPortugal (866) and \n\nSpain (756)\n\nthe remaining 7,324 were distributed among 56 other countries. \n\nFatal, 1,223\n\nSince Dec. 11, 2020, the Pfizer-BioNTech COVID-19 Vaccine has been available under EUA \n\nhttps://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine\n\n(Approval, 21st August 2021)\n\nActing FDA Commissioner Janet Woodcock, M.D.\n\nWhile millions of people have already safely received COVID-19 vaccines, we recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated. \n\nToday\u2019s milestone puts us one step closer to altering the course of this pandemic in the U.S.\n\nSystem Organ Classes (SOCs)\n\nthat contained the greatest number (\u22652%) of events, in the overall dataset, \n\nwere General disorders and administration site conditions (51,335 AEs), \n\nNervous system disorders (25,957), \n\nMusculoskeletal and connective tissue disorders (17,283), \n\nGastrointestinal disorders (14,096), \n\nSkin and subcutaneous tissue disorders (8,476), \n\nRespiratory, thoracic and mediastinal disorders (8,848), \n\nInfections and infestations (4,610), \n\nInjury, poisoning and procedural complications (5,590), and Investigations (3,693). \n\nCardiovascular AESIs \n\nNumber of cases: 1403 (3.3% of the total PM dataset), \n\nof which 241 are medically confirmed and 1162 are non-medically confirmed; \n\n5. SUMMARY AND CONCLUSION \nReview of the available data for this cumulative PM experience, confirms a favorable benefit: risk balance for BNT162b2. \n\nPeter Marks, M.D., Ph.D., director of FDA\u2019s Center for Biologics Evaluation and Research\n\n\u201cOur scientific and medical experts conducted an incredibly thorough and thoughtful evaluation of this vaccine. \n\nWe evaluated scientific data and information included in hundreds of thousands of pages, conducted our own analyses of Comirnaty\u2019s safety and effectiveness, \n\nand performed a detailed assessment of the manufacturing processes, including inspections of the manufacturing facilities,\u201d\n\n\u201c\u2026.. the public is counting on safe and effective vaccines. The public and medical community can be confident that although we approved this vaccine expeditiously, it was fully in keeping with our existing high standards for vaccines in the U.S.\"\n\nhttps://childrenshealthdefense.org/defender/fda-releases-pfizer-vaccine-documents/?itm_term=home\n\nAustria\n\nhttps://www.nytimes.com/live/2022/03/09/world/covid-19-mandates-cases-vaccine\n\nKaroline Edtstadler\n\nthe law, passed in January, in force since early February, \n\nnot proportionate, relatively mild symptoms experienced by most people who contract Omicron", "link": "https://www.youtube.com/watch?v=7YOD9drZasM", "date_published": "2022-03-09 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]